首页> 外文期刊>Proceedings of the National Academy of Sciences of the United States of America >THE 37/40-KILODALTON AUTOANTIGEN IN INSULIN-DEPENDENT DIABETES MELLITUS IS THE PUTATIVE TYROSINE PHOSPHATASE IA-2
【24h】

THE 37/40-KILODALTON AUTOANTIGEN IN INSULIN-DEPENDENT DIABETES MELLITUS IS THE PUTATIVE TYROSINE PHOSPHATASE IA-2

机译:胰岛素依赖型糖尿病中的37 / 40-KILODALTON自身抗原是酪氨酸磷酸酶IA-2

获取原文
获取原文并翻译 | 示例
       

摘要

Major targets for autoantibodies associated with the development of insulin-dependent diabetes mellitus (IDDM) include tryptic fragments with a molecular mass of 37 kDa and/or 40 kDa of a pancreatic islet cell antigen of unknown identity, The assay identifying autoantibodies against the 37/40-kDa antigen in human sera is based on the immunoprecipitation of S-35-labeled rat insulinoma cell proteins with sera from IDDM patients, followed by limited trypsin digestion of the immunoprecipitated material, To identify cDNA clones coding for the 37/40-kDa antigen, we have screened a cDNA expression library from rat insulinoma cells with a serum from an IDDM patient that precipitated the 37/40-kDa antigen in our assay, Among the cDNA products that reacted with the IDDM serum, we identified one cDNA clone whose open reading frame encodes a protein with a predicted mass of 105 kDa that we termed ''ICA105'' for 105-kDa islet cell antibody, The deduced amino acid sequence has high homology to a recently cloned putative tyrosine phosphatase IA-2 from human and mouse cDNA libraries, Translation of the cDNA in vitro results in a polypeptide with the expected molecular mass of 105 kDa, The evidence that ICA105 is indeed the precursor of the 37/40-kDa tryptic fragments is based on the following three results: (i) Sera from IDDM patients containing autoantibodies to the 37/40-kDa antigen precipitate the in vitro translated polypeptide, whereas sera from healthy subjects as well as sera from IDDM patients not reactive with the 37/40-kDa antigen do not precipitate the cDNA product, (ii) Immunoprecipitation of the in vitro translated protein with sera containing autoantibodies to the 37/40-kDa antigen followed by limited trypsin digestion of the precipitated proteins results in a 40-kDa polypeptide. (iii) The protein derived from our cDNA but not from an unrelated control cDNA clone fan block immunoprecipitation of the 37/40-kDa antigen from a labeled rat insulinoma cell extract, The availability of the cloned 37/40-kDa antigen should facilitate the identification of individuals at risk of IDDM with increased accuracy, Furthermore, the identification of the 37/40-kDa antigen as the putative tyrosine phosphatase IA-2 is of relevance in elucidating the role of this antigen in the development of IDDM. [References: 21]
机译:与胰岛素依赖型糖尿病(IDDM)的发展相关的自身抗体的主要目标包括分子量为37 kDa和/或40 kDa未知身份的胰岛细胞抗原的胰蛋白酶片段,鉴定针对37 /人血清中的40 kDa抗原基于IDDM患者血清对S-35标记的大鼠胰岛素瘤细胞蛋白的免疫沉淀作用,然后用胰蛋白酶对免疫沉淀物进行有限的消化,以鉴定编码37/40 kDa的cDNA克隆抗原,我们从大鼠胰岛素瘤细胞中筛选了一个IDDM患者血清的cDNA表达文库,该血清在我们的测定中沉淀了37 / 40-kDa抗原。在与IDDM血清反应的cDNA产物中,我们鉴定了一个cDNA克隆,其开放阅读框编码一种预测质量为105 kDa的蛋白质,我们将其称为105-kDa胰岛细胞抗体的“ ICA105”。推导的氨基酸序列与rec从人和小鼠cDNA文库中克隆了假定的酪氨酸磷酸酶IA-2,体外cDNA的翻译产生了预期分子量为105 kDa的多肽。证据表明ICA105确实是37/40 kDa胰蛋白酶的前体。片段基于以下三个结果:(i)含有针对37 / 40-kDa抗原的自身抗体的IDDM患者的血清沉淀体外翻译的多肽,而健康受试者的血清以及IDDM患者的血清与37 / 40-kDa抗原不会沉淀cDNA产物,(ii)用含有针对37 / 40-kDa抗原的自身抗体的血清对体外翻译的蛋白质进行免疫沉淀,然后用胰蛋白酶对沉淀的蛋白质进行有限的消化,得到40-kDa的多肽。 (iii)来源于我们的cDNA的蛋白,而不是来自无关对照cDNA克隆的蛋白,阻碍了标记大鼠胰岛素瘤细胞提取物中37 / 40-kDa抗原的免疫沉淀。克隆37 / 40-kDa抗原的可用性应有助于以较高的准确性鉴定具有IDDM风险的个体。此外,鉴定37 / 40-kDa抗原作为假定的酪氨酸磷酸酶IA-2与阐明该抗原在IDDM发育中的作用有关。 [参考:21]

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号